Patent Protection for Pharma and Biotechnology in 2018
Live Webcast Date:
Friday, January 26, 2018 from 12:00 pm to 1:30 pm (ET)
Online CLE Patent Protection Pharma Biotech
Listen as a panel of distinguished industry experts and thought leaders organized by The Knowledge Group provide the audience with in-depth discussion of the important patent issues in pharma and biotechnology industries for 2018. The speakers will provide best practices in protecting patents against infringement and overcoming patent invalidation.
In a Webcast, the speakers will discuss:
- Recent Life Sciences Federal Circuit Decisions
- Key Legislative and Litigation Developments
- Impact of these Developments on Patent Protection
- Strategic Approaches to Patent Eligibility
- Best Practices
Agenda
SEGMENT 1:
Adelaide Leitzel, Ph.D., Patent Agent
Taft Stettinius & Hollister LLP
- Life Sciences Patent Eligibility Cases- post Myriad
- Patent Eligibility Flowchart
- Crispr Background
- Crispr PTAB Decision
- Inventor Statements
- Prosecution Tips
SEGMENT 2:
Jennifer Hayes, Partner
Sughrue Mion, PLLC
- Definition of anticipation
- Definition of inherency
- Claim construction and inherency
- Differing standards of inherent anticipation for enablement and prior art
- New methods of use vs. inherent properties
- Inherent anticipation caselaw
- Prosecution strategies
SEGMENT 3:
Kurt Briscoe, Member
Norris McLaughlin & Marcus, P.A.
- Bayer v. Watson, Merck v. Hospira: Role of Secondary Considerations in Formulation Obviousness
- Amgen v. Sanofi: Use of Post-Priority-Date Evidence to Prove a Patent Lacks Written Description of a Claimed Genus
Who Should Attend
- Biotech/Pharma Industry Lawyers
- In-House Counsel for Pharma/Biotech & Drug Manufacturing Companies
- Executives coming from Biotech and Pharmaceutical Firms
- Patent Attorneys
- Patent Consultants
- Patent Litigators
- Drug Manufacturing Executives
- Other Related and Interested Professionals
Online CLE Patent Protection Pharma Biotech
SEGMENT 1:
Adelaide Leitzel, Ph.D., Patent Agent
Taft Stettinius & Hollister LLP
- Life Sciences Patent Eligibility Cases- post Myriad
- Patent Eligibility Flowchart
- Crispr Background
- Crispr PTAB Decision
- Inventor Statements
- Prosecution Tips
SEGMENT 2:
Jennifer Hayes, Partner
Sughrue Mion, PLLC
- Definition of anticipation
- Definition of inherency
- Claim construction and inherency
- Differing standards of inherent anticipation for enablement and prior art
- New methods of use vs. inherent properties
- Inherent anticipation caselaw
- Prosecution strategies
SEGMENT 3:
Kurt Briscoe, Member
Norris McLaughlin & Marcus, P.A.
- Bayer v. Watson, Merck v. Hospira: Role of Secondary Considerations in Formulation Obviousness
- Amgen v. Sanofi: Use of Post-Priority-Date Evidence to Prove a Patent Lacks Written Description of a Claimed Genus
Online CLE Patent Protection Pharma Biotech
Kurt BriscoeMemberNorris McLaughlin & Marcus, P.A.
Kurt G. Briscoe, a Member of Norris McLaughlin & Marcus, P.A., devotes his practice to patent, trademark, and other intellectual property matters. He has over 25 years of experience in intellectual property law, including five years, from 1983 to 1988, as an examiner in the United States Patent and Trademark Office. Most of Kurt’s practice, including his experience as a patent examiner, has been in the field of pharmaceuticals and biotechnology. Kurt regularly represents domestic and international companies in connection with the preparation and prosecution of patent and trademark applications. In addition, he regularly negotiates licensing and nondisclosure agreements for these clients. Kurt provides experienced worldwide IP portfolio management, including strategic, freedom-to-operate, invalidity, and infringement opinions. Kurt also performs due diligence for clients prior to their acquisition of patents and trademarks to reveal any patent validity or enforceability problems, or patent prosecution events that impact patent claim scope.
Adelaide Leitzel, Ph.D.Patent AgentTaft Stettinius & Hollister LLP
DR. ADELAIDE K. LEITZEL, a registered patent agent, holds a Ph.D. in genetics and molecular biology from the University of North Carolina and received her undergraduate degree in biology and history from Davidson College in Davidson, North Carolina. She has extensive experience in drafting and prosecuting patent applications for inventions from diverse areas including genetics, transgenic animals, immunology, bacteriology, cardiology, nephrology, pulmonology, diagnostic methods, transgenic plants, plant pathology, and plant development. Her research was published in the journal Yeast. Dr. Leitzel is a registered patent agent with the U.S. Patent and Trademark Office. She practices in the area of Patent Prosecution with a focus on Life Sciences. Dr. Leitzel has published multiple articles on the unique aspects of life sciences patent prosecution, especially the Myriad decisions.
Jennifer HayesPartnerSughrue Mion, PLLC
Jennifer M. Hayes is a Partner with Sughrue, Mion, PLLC in Washington, D.C. Mrs. Hayes has also worked at the U.S. Patent and Trademark Office as a Patent Examiner and as a Petitions Attorney in the Office of Petitions. Mrs. Hayes is a registered patent attorney and specializes in pharmaceutical, chemical and biotech patent prosecution. Mrs. Hayes practice includes all phases of patent prosecution, including, preparing and prosecuting original patent applications, reissue applications and applications for patent term extension. She also advises clients on patentability, patent validity, and infringement.
Mrs. Hayes is a graduate of Howard University College of Pharmacy (B.S. 1991) and Howard University School of Law (J.D. 1994). Mrs. Hayes received a Master of Laws in Intellectual Property Law from The George Washington University Law School in May of 2002. She is a member of the Maryland State Bar, the District of Columbia Bar, the U.S. Court of Appeals for the Federal Circuit, and the Untied States Supreme Court.
Mrs. Hayes travels to Japan frequently to visit clients, where she gives lectures on topics of interests including recent developments in U.S. Patent Law. Mrs. Hayes also serves as a member of the Board of the Institute for Intellectual Property and Social Justice (IIPSJ) at the Howard University School of Law and frequently participates as a speaker and has coordinated sponsorships for the IIPSJ's annual Continuing Legal Education (CLE) program.
Prior to entering the area of patent law, Mrs. Hayes was a registered pharmacist in the state of Maryland.
Online CLE Patent Protection Pharma Biotech
Course Level:
Intermediate
Advance Preparation:
Print and review course materials
Method Of Presentation:
On-demand Webcast
Prerequisite:
Experience in Patent/Life Sciences Law
Course Code:
147086
NY Category of CLE Credit:
Areas of Professional Practice
Total Credits:
1.5 CLE
No Access
You are not logged in. Please Login or register to the event to gain access to the materials and login instructions.
About the Knowledge Group
The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.
Speaker Firms
Click firm logo/firm name to learn more
Faculty
Click show bio to learn more
Kurt Briscoe
Member
Norris McLaughlin & Marcus, P.A.
Member
Norris McLaughlin & Marcus, P.A.
Adelaide Leitzel, Ph.D.
Patent Agent
Taft Stettinius & Hollister LLP
Patent Agent
Taft Stettinius & Hollister LLP
Jennifer Hayes
Partner
Sughrue Mion, PLLC
Partner
Sughrue Mion, PLLC
About the Knowledge Group
The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.
Norris McLaughlin & Marcus is a mid-sized, regional law firm that serves the legal needs of businesses and families in New Jersey, New York, and Pennsylvania. The firm is uniquely positioned to represent middle-market companies, Fortune 500 corporations, and individuals. Norris McLaughlin & Marcus is attentive and responsive to the needs of established and emerging middle-market, privately-owned companies, providing quality and comprehensive legal services. They are dedicated to the success of their clients, whether in a transaction, in court, or in the course of everyday business. The firm brings niche industry experience to companies that may have outgrown their existing legal service provider or need more experience, resources, and in-depth knowledge of their particular market.
Website: https://www.nmmlaw.com/
Intellectual property is a significant asset for companies in today’s competitive landscape. Protecting that asset is critical. Intellectual property is more than patents and trademarks — it is the people, practices and big ideas that keep a business running. No matter the industry, organizations need legal counsel that can identify, protect and enforce their ongoing IP rights and that can secure their freedom to operate in the marketplace.
Taft’s team of Intellectual Property attorneys focuses on providing comprehensive legal strategies to support clients’ needs and goals. Our group consists of more than 60 attorneys, including more than 30 registered patent attorneys and agents, who are well-positioned with the experience and connections to protect our clients’ IP needs.
In addition to patent, trademark, and copyright protection and litigation, our IP attorneys advise clients on the trade secret protection, unfair competition, false advertising and the right of publicity. We have experience representing clients across industries, including financial services, software development, electric manufacturing, specialty chemicals, security, automotive, entertainment, and health care.
Our attorneys assist clients in a range of traditional and innovative IP matters, from drafting licensing and development agreements and handling disputes to assisting individuals and institutions from early research through commercialization. We have experience litigating suits regarding involving technologies such as avionics, LCD optics, video signaling, semiconductor design and operation, thin film transistor manufacturing and design, voice-over-internet telephony and firewalls, routers and switches, network topology and message routing, LED design and operation, PECVD manufacturing processes, regulated medical devices, pharmaceutically active substances and formulations, cellular screening methods, computer software and electronic point of sale devices.
Taft’s patent prosecution team consists of 25 registered patent attorneys and one patent agent that practice before the U.S. Patent and Trademark Office and prepare and prosecute patent applications in a broad range of technologies. We provide patentability studies and opinions; right-to-use (non-infringement) studies and opinions; patent license preparation and negotiation; and client counseling relating to both client and competitor patents and related technologies.
While we regularly guide clients through all stages of litigation, including appeals, the goal is always to avoid and resolve potential disputes before they reach that point or, at the very least, to achieve a successful result as quickly and efficiently as possible.
Website: https://www.taftlaw.com/
Drawing from the experience of over eighty registered patent and trademark attorneys, Sughrue Mion offers unmatched expertise in a wide range of intellectual property matters. With over seventy patent attorneys, each holding degrees in the electrical, mechanical, physical, biological and/or chemical arts, we offer the unique ability to staff project teams with attorneys having a specialty matched to our clients’ needs. Our ability to succeed in specialized IP forums is built upon our recognized strength and leadership in patent law, both before the U.S. Patent and Trademark Office and before the U.S. federal courts and international trade courts. Historically, Sughrue Mion ranks in the top firms for the number of patents obtained from the U.S. Patent Office and also led the rankings in the number of trademark filings. From offices in Washington, D.C. and Tokyo, Sughrue Mion is proud to serve the world’s largest patent and trademark holders.
Website: jhayes@sughrue.com
Kurt G. Briscoe, a Member of Norris McLaughlin & Marcus, P.A., devotes his practice to patent, trademark, and other intellectual property matters. He has over 25 years of experience in intellectual property law, including five years, from 1983 to 1988, as an examiner in the United States Patent and Trademark Office. Most of Kurt’s practice, including his experience as a patent examiner, has been in the field of pharmaceuticals and biotechnology. Kurt regularly represents domestic and international companies in connection with the preparation and prosecution of patent and trademark applications. In addition, he regularly negotiates licensing and nondisclosure agreements for these clients. Kurt provides experienced worldwide IP portfolio management, including strategic, freedom-to-operate, invalidity, and infringement opinions. Kurt also performs due diligence for clients prior to their acquisition of patents and trademarks to reveal any patent validity or enforceability problems, or patent prosecution events that impact patent claim scope.
DR. ADELAIDE K. LEITZEL, a registered patent agent, holds a Ph.D. in genetics and molecular biology from the University of North Carolina and received her undergraduate degree in biology and history from Davidson College in Davidson, North Carolina. She has extensive experience in drafting and prosecuting patent applications for inventions from diverse areas including genetics, transgenic animals, immunology, bacteriology, cardiology, nephrology, pulmonology, diagnostic methods, transgenic plants, plant pathology, and plant development. Her research was published in the journal Yeast. Dr. Leitzel is a registered patent agent with the U.S. Patent and Trademark Office. She practices in the area of Patent Prosecution with a focus on Life Sciences. Dr. Leitzel has published multiple articles on the unique aspects of life sciences patent prosecution, especially the Myriad decisions.
Jennifer M. Hayes is a Partner with Sughrue, Mion, PLLC in Washington, D.C. Mrs. Hayes has also worked at the U.S. Patent and Trademark Office as a Patent Examiner and as a Petitions Attorney in the Office of Petitions. Mrs. Hayes is a registered patent attorney and specializes in pharmaceutical, chemical and biotech patent prosecution. Mrs. Hayes practice includes all phases of patent prosecution, including, preparing and prosecuting original patent applications, reissue applications and applications for patent term extension. She also advises clients on patentability, patent validity, and infringement.
Mrs. Hayes is a graduate of Howard University College of Pharmacy (B.S. 1991) and Howard University School of Law (J.D. 1994). Mrs. Hayes received a Master of Laws in Intellectual Property Law from The George Washington University Law School in May of 2002. She is a member of the Maryland State Bar, the District of Columbia Bar, the U.S. Court of Appeals for the Federal Circuit, and the Untied States Supreme Court.
Mrs. Hayes travels to Japan frequently to visit clients, where she gives lectures on topics of interests including recent developments in U.S. Patent Law. Mrs. Hayes also serves as a member of the Board of the Institute for Intellectual Property and Social Justice (IIPSJ) at the Howard University School of Law and frequently participates as a speaker and has coordinated sponsorships for the IIPSJ's annual Continuing Legal Education (CLE) program.
Prior to entering the area of patent law, Mrs. Hayes was a registered pharmacist in the state of Maryland.
